Carbo-acyclic nucleoside derivatives as antiviral and...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 473/00 (2006.01) A61K 31/435 (2006.01) A61K 31/505 (2006.01) C07D 239/46 (2006.01) C07D 239/52 (2006.01) C07D 239/54 (2006.01) C07D 471/04 (2006.01)

Patent

CA 2165419

The present invention is directed to a class of novel carbo-acyclic derivatives having formulas (I) and (II) and their use as anti-viral and anti-neoplastic agents, Wherein X1 and X2 are each independently hydrogen, fluorine, or chlorine, R is hydrogen or hydroxymethyl, J is a radical of formulas (a), (b) and (c). Y1 is a CH group, a CCI group, a CBr group or a CNH2 group, Y2 and Y3 are each independently nitrogen or a CH group, Y1 is a CH group, a CCI group, a CBr group or a CNH2 group, Y2 and Y3 are each independently nitrogen or a CH group, Y4 is hydrogen, C1-C4 alkyl, C1-C4 alkoxy or halogen, Y5 is NH2 or C1-C4 alkoxy, Q is NH2, NHOH, NHCH3, OH, or hydrogen, and V is hydrogen, halogen or NH2; or a pharmaceutically acceptable salt thereof.

La présente invention concerne une classe de nouveaux dérivés carbo-acycliques ayant les formules (I) et (II), ainsi que leur utilisation comme agents antiviraux et antinéoplasiques. Dans ces formules: X1 et X2 représentent chacun indépendamment hydrogène, fluor ou chlore, R représente hydrogène ou un hydroxyméthyle, J représente un radical des formules (a), (b), (c), dans lesquelles Y1 représente un groupe CH, un groupe CCl, un groupe CBr ou un groupe CNH2, et Y2 et Y3 représentent chacun indépendamment azote ou un groupe CH, Y4 représente hydrogène, alkyleC1-C4, alcoxyC1-C4 ou halogène, Y5 représente NH2 ou alcoxyC1-C4, Q représente NH2, NHOH, NHCH3, OH ou hydrogène et V représente hydrogène, halogène ou NH2. L'invention concerne également un sel de ces composés acceptable sur le plan pharmaceutique.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Carbo-acyclic nucleoside derivatives as antiviral and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Carbo-acyclic nucleoside derivatives as antiviral and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Carbo-acyclic nucleoside derivatives as antiviral and... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2060795

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.